Li-Ping Teng Selected Research

niga-ichigoside F1

2/2018

Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Ping Teng Research Topics

Disease

3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2015 - 08/2014
2	Anemia 12/2014 - 08/2014
1	Non-alcoholic Fatty Liver Disease 02/2018
1	Fever (Fevers) 02/2017
1	Rheumatic Diseases (Rheumatism) 02/2017
1	Neoplasms (Cancer) 07/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2014
1	Lung Diseases (Lung Disease) 08/2014

Drug/Important Bio-Agent (IBA)

1	Hypolipidemic Agents (Antihyperlipidemics)IBA 02/2018
1	niga-ichigoside F1IBA 02/2018
1	AntioxidantsIBA 02/2018
1	LipidsIBA 02/2018
1	Interleukin-10 (Interleukin 10)IBA 02/2017
1	Ferritins (Ferritin)IBA 02/2017
1	Methotrexate (Mexate)FDA LinkGeneric 07/2016
1	MicellesIBA 07/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2016
1	EstersIBA 07/2016
1	Vitamin D FDA LinkGeneric 04/2015
1	hydroxide ionIBA 04/2015
1	CytokinesIBA 12/2014
1	Interleukin-6 (Interleukin 6)IBA 12/2014
1	Immunoglobulin G (IgG)IBA 08/2014
1	Antinuclear AntibodiesIBA 08/2014
1	1-dodecylpyridoxal (PLD)IBA 08/2014

Therapy/Procedure

1	Therapeutics 07/2016